SCHEMBL18201985

SCHEMBL18201985

CCCc1ccc(OC(C=O)c2ccc(OCC)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.40
NQO1 P15559 1/20 0.40
ACACB O00763 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GPR84 Q9NQS5 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
ACACA Q13085 1/20 0.38
MAPT P10636 1/20 0.38
CNR2 P34972 1/20 0.37
SLC5A1 P13866 1/20 0.37
SLC5A2 P31639 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18201981 0.85 SMN1; SMN2 (0.46) NQO1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL18201982 0.81 LMNA (0.53) PPARGPPARACNR2L3MBTL1SMN1; SMN2
SCHEMBL8699347 0.79 THRB (0.39) THRBACACBALDH1A1GPR84PPARG
SCHEMBL7753262 0.78 NQO1 (0.67) THRBNQO1ACACBALDH1A1MAPT
SCHEMBL25548946 0.76 NQO1 (0.64) THRBNQO1ACACBALDH1A1GPR84
SCHEMBL7347411 0.73 THRB (0.47) THRBACACBALDH1A1PPARGPPARA
SCHEMBL10613369 0.72 NQO1 (0.58) THRBNQO1ALDH1A1MAPTL3MBTL1
SCHEMBL17614864 0.72 NQO1 (0.58) THRBNQO1ALDH1A1MAPTL3MBTL1
SCHEMBL18952990 0.72 KMT2A (0.42) THRBACACBALDH1A1PPARGPPARA
SCHEMBL15330491 0.71 NQO1 (0.56) NQO1ACACBACACATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016176473-A1 APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF SANFORD-BURNHAM MEDICAL RESEARC INSTITUTE (US) 2016-11-03 WO disclosed